A lmod1a mutation causes megacystis microcolon intestinal hypoperistalsis in a CRISPR/Cas9-modified zebrafish model
Topic overview
Researchers used CRISPR/Cas9 to create a zebrafish model of MMIHS by deleting the lmod1a gene, successfully replicating the intestinal hypoperistalsis seen in human patients. The model showed reduced expression of key smooth muscle genes and impaired gut motility, offering a platform for testing future therapies including drug screening and gene repair approaches for this rare congenital disorder.
Key takeaways
- CRISPR/Cas9-induced lmod1a deletion in zebrafish successfully models MMIHS with intestinal hypoperistalsis phenotype.
- Lmod1a mutation causes downregulation of smooth muscle genes (myh11, acta2) and proteins critical to intestinal motility.
- Mutant zebrafish show quantifiable peristalsis defects: fewer, slower, and shorter contractions versus wild-type controls.
- This zebrafish MMIHS model enables future drug screening and gene therapy development for this rare congenital myopathy.
- Five-base-pair deletion in lmod1a exon 1 creates premature stop codon, recapitulating human MMIHS genetic pathophysiology.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. A lmod1a mutation causes megacystis microcolon intestinal hypoperistalsis in a CRISPR/Cas9-modified zebrafish model. GlobalCastMD Medical Library. 2024-08-14. https://dev.library.globalcastmd.com/article/9002?via_space=staycurrentmd
Comments